Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andrew T. Faucheux"'
Autor:
Alexander H. Song, Robin M. Petro, M. Porosnicu, Arianne Abreu, Kiarash Salafian, Ralph B. D'Agostino, Harper L. Wilson, Manisha Jayandra Patel, Cristina M. Furdui, Thomas Lycan, Umit Topaloglu, Wei Zhang, Kimberly M. Burcher, Andrew T. Faucheux, Jeffrey Lantz
Publikováno v:
Cancers, Vol 13, Iss 3118, p 3118 (2021)
Cancers
Volume 13
Issue 13
Cancers
Volume 13
Issue 13
Simple Summary The DNA damage repair (DDR) gene profile is largely unexplored in head and neck squamous cell cancer (HNSCC), leaving little known about the treatment of HNSCC with PARP inhibitors. In this retrospective study, the prevalence of mutate
Autor:
Andy Dothard, Andrew T. Faucheux, Janardhana Ponnatapura, Eric Olson, JiaHao Liang, Thomas Lycan, Nathan Roberts, Jeffrey Lantz
Publikováno v:
Regular and young investigator award abstracts.
Background Optimal diagnostic algorithm to differentiate checkpoint inhibitor pneumonitis (CIP) from mimics is uncertain; patients with respiratory comorbidities often receive prolonged corticosteroids until diagnostic clarification. Drawbacks to emp
Autor:
Alexander H. Song, Jack T. Burcher, Umit Topaloglu, Paul M. Bunch, Wei Zhang, Kimberly M. Burcher, Ryan T. Hughes, Elena Gavrila, Clayton Jackson, Thomas Lycan, Arianne Abreu, Ralph B. D'Agostino, M. Porosnicu, Andrew T. Faucheux, Jeffrey Lantz, Amy Xie, Cristina M. Furdui
Publikováno v:
Cancers
Volume 13
Issue 22
Cancers, Vol 13, Iss 5733, p 5733 (2021)
Volume 13
Issue 22
Cancers, Vol 13, Iss 5733, p 5733 (2021)
Simple Summary Immunotherapy has prompted a dramatic change in the management of head and neck squamous cell carcinoma (HNSCC), but the percentage of patients benefiting from treatment is limited to 20% or less. The application of precision oncology
Autor:
Gregory B. Russell, Vanya Aggarwal, Ella M. LePage, Hiral S. Patel, Eric Olson, Thomas Lycan, Andrew T. Faucheux, Jared Rejeski
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundImmune-mediated diarrhea or colitis (IDC) is a potentially serious adverse event which can occur in up to 10% of patients receiving an immune checkpoint inhibitor (ICIs), but not all episodes of diarrhea among these patients are immune-medi
Autor:
Manisha Jayandra Patel, Alexander H. Song, Wei Zhang, Arianne Abreu, Ralph B. D'Agostino, Andrew T. Faucheux, Kimberly M. Burcher, Umit Topaloglu, M. Porosnicu, Cristina M. Furdui, Jeffrey Lantz
Publikováno v:
Journal of Clinical Oncology. 39:e18016-e18016
e18016 Background: Next generation sequencing (NGS) has introduced the opportunity for targeted therapies and guidance regarding disease course and prognosis. The mutational landscape of squamous cell cancers of the head and neck (HNSCC) remains inco